Abbott reinforces ophthalmology position with $400m Visiogen buy
This article was originally published in Clinica
Executive Summary
Following its acquisition of Advanced Medical Optics in February, Abbott has furthered strengthened its new ophthalmology portfolio by purchasing intraocular lens (IOL) specialist Visiogen for $400m.